Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis in Donor-Recipient Pairs after Allogeneic Hematopoietic Cell Transplantation

Masumi Ueda, MD, Lan Beppu, Judy Campbell, RN, Mary E. D. Flowers, MD, Jerald P. Radich, MD, Rainer Storb, MD

Blood (2019) 134 (Supplement_1): 702.

https://doi.org/10.1182/blood-2019-126979

Published: 2019

Journal Articles

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Brian Kornblit, MD PhD, Barry Storer, Michael B. Maris, MD, Niels Smedegaard Andersen, MD PhD, Thomas R. Chauncey, MD PhD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, David G. Maloney, MD PhD, Rainer Storb, MD, Brenda M Sandmaier, MD

Blood (2019) 134 (Supplement_1): 369.

https://doi.org/10.1182/blood-2019-123196

Published: 2019

Journal Articles

Characterization of Clonal Dynamics after Hematopoietic Cell Transplantation Using Ultra-Sensitive Duplex Sequencing

Jacob Higgins, PhD, Gabriel Pratt, PhD, Charles C. Valentine, MS, Lindsey N. Williams, PhD, Masumi Ueda, MD, Rainer Storb, MD, Jerald P. Radich, MD, Jesse J. Salk, MD PhD

Blood (2019) 134 (Supplement_1): 2483.

https://doi.org/10.1182/blood-2019-122490

Published: 2019

Journal Articles

A Prospective Multicenter Study of Nonmyeloablative Conditioning with TBI or Fludarabine/TBI for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and Mycophenolate Mofetil: 10-Year Experience

Huiying Qiu, MD, Brenda M. Sandmaier, MD, Barry E. Storer, PhD, Thomas Chauncey, MD PhD, Finn Petersen, MD, Michael A. Pulsipher, Benedetto Bruno, MD, Mary Flowers, MD, Marco Mielcarek, MD, Rainer Storb, MD, David G Maloney, MD PhD

Blood (2015) 126 (23): 1949.

https://doi.org/10.1182/blood.V126.23.1949.1949

Published: 2015

Journal Articles

Anti-CD45 Monoclonal Antibody (MAb) Dose Optimization For Astatine-211 ( 211 At)-Radioimmunotherapy (RIT) Of Relapsed Non-Hodgkin Lymphoma (NHL) In a Canine Model

Sofia H.L. Frost, PhD, Erlinda B. Santos, BS, Brian W. Miller, PhD, Tom A. Bäck, PhD, Donald K. Hamlin, BS, D. Scott Wilbur, PhD, Aimee L. Kenoyer, BS, Shani L. Frayo, BS, Oliver W. Press, MD, PhD, Rainer Storb, MD, Brenda M. Sandmaier, MD, John M. Pagel, MD, PhD

Blood (2013) 122 (21): 5139.

https://doi.org/10.1182/blood.V122.21.5139.5139

Published: 2013

Journal Articles

Modulated Cyclophosphamide-Based In Vivo T-Cell Depletion Promotes Engraftment With Minimal Gvhd and Low Toxicity In Fanconi Anemia Patients

Monica S Thakar, MD, Mark C. Walters, MD, Brenda M. Sandmaier, MD, Rainer Storb, MD, Mary E. D. Flowers, MD, H. Joachim Deeg, MD, Paul O'Donnell, MD, PhD, Ann E. Woolfrey, MD, Hans-Peter Kiem, MD

Blood (2013) 122 (21): 4561.

https://doi.org/10.1182/blood.V122.21.4561.4561

Published: 2013

Journal Articles

Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Roland B. Walter, MD, PhD, Boglarka Gyurkocza, MD, Barry E. Storer, PhD, John M. Pagel, MD, PhD, Sarah A. Buckley, MD, Mohamed L. Sorror, MD, MSc, Colleen Delaney, MD, MSc, Brent L. Wood, MD, PhD, H. Joachim Deeg, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD

Blood (2013) 122 (21): 1317.

https://doi.org/10.1182/blood.V122.21.1317.1317

Published: 2013

Journal Articles

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Marco Mielcarek, MD, Terrence Furlong, Barry E. Storer, PhD, Margaret L. Green, MD, Paul A. Carpenter, MD, George B McDonald, MD, Mary E. D. Flowers, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Michael Boeckh, MD, Paul J. Martin, MD

Blood (2013) 122 (21): 703.

https://doi.org/10.1182/blood.V122.21.703.703

Published: 2013

Journal Articles

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

Merav Bar, MD, Barry Storer, PhD, Benedetto Bruno, MD, Parameswaran Hari, MBBS, MD, MRCP, Thomas Chauncey, MD, PhD, Yoshihiro Inamoto, MD, PhD, Paul J. Martin, MD, Rainer Storb, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mary E.D. Flowers, MD

Blood (2012) 120 (21): 354.

https://doi.org/10.1182/blood.V120.21.354.354

Published: 2012

Journal Articles

A Phase II Trial Combining Radiolabeled Anti-CD45 Antibody with Fludarabine and Low-Dose Total Body Irradiation (TBI) Followed by Related or Unrelated Hematopoietic Cell Transplantation for Patients Under Age 50 with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Raya Mawad, MD, Ted A. Gooley, PhD, Joseph G Rajendran, MD, Darrell R. Fisher, PhD, Ajay K. Gopal, MD, H. Joachim Deeg, MD, Andrew Shields, MD, Damian J. Green, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Oliver W. Press, MD, PhD, John M. Pagel, MD, PhD

Blood (2012) 120 (21): 1924.

https://doi.org/10.1182/blood.V120.21.1924.1924

Published: 2012

Journal Articles

Inducible Costimulator (ICOS) Is up-Regulated in Dogs with Graft Versus Host Disease and Graft Rejection Following Non-Identical Hematopoietic Cell Transplantation

Scott Stoll Graves, PH.D., Masahiko Sato, DVM, Ph.D., Carol Loretz, BS, Stone Diane, BS, Rainer Storb, MD

Blood (2012) 120 (21): 4109.

https://doi.org/10.1182/blood.V120.21.4109.4109

Published: 2012

Journal Articles

Hematopoietic Bone Marrow Transplantation (BMT) for Patients with High-Risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS) Using HLA-Haploidentical Related Donors: A Trial Using Radiolabeled Anti-CD45 Antibody Combined with Immunosuppression Before and After BMT

Raya Mawad, MD, Paul O'Donnell, MD, PhD, Ted A. Gooley, PhD, Joseph G Rajendran, MD, Darrell R. Fisher, PhD, Ajay K. Gopal, MD, H. Joachim Deeg, MD, Andrew Shields, MD, Damian J. Green, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Oliver W. Press, MD, PhD, John M. Pagel, MD, PhD

Blood (2012) 120 (21): 4164.

https://doi.org/10.1182/blood.V120.21.4164.4164

Published: 2012

Journal Articles

Vaccinating Female Donors with Y Chromosome-Encoded Disparities in the Pre-Clinical Canine Model of Allogeneic Hematopoietic Cell Transplantation

Steven Lawrence Rosinski, M.D., Ph.D., Scott Stoll Graves, PH.D., Rainer Storb, MD, Brad Stone, PhD

Blood (2012) 120 (21): 4123.

https://doi.org/10.1182/blood.V120.21.4123.4123

Published: 2012

Journal Articles

Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts

Boglarka Gyurkocza, M.D., Rainer Storb, MD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Barry Storer, PhD, Brenda M. Sandmaier, MD

Blood (2012) 120 (21): 4207.

https://doi.org/10.1182/blood.V120.21.4207.4207

Published: 2012

Journal Articles

Long-Term Tolerance to Kidney Allografts After Induced Rejection of Donor Hematopoietic Chimerism in a Preclinical Canine Model.

David Mathes, MD, Scott Stoll Graves, PH.D., George E. Georges, MD, Christian Kuhr, MD, Jeff Chang, MD, Tiffany Butts, BA, Rainer Storb, MD

Blood (2012) 120 (21): 2991.

https://doi.org/10.1182/blood.V120.21.2991.2991

Published: 2012

Journal Articles

Impact of Pre-Transplant Comorbidities on the Rate of- and Mortality-Following Acute Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Rainer Storb, MD, Paul J Martin, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Ted A. Gooley, PhD

Blood (2011) 118 (21): 156.

https://doi.org/10.1182/blood.V118.21.156.156

Published: 2011

Journal Articles

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Mohamed L. Sorror, MD, MSc, Fabiana Ostronoff, MD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J Martin, MD, Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M Sandmaier, MD, Barry Storer, PhD

Blood (2011) 118 (21): 145.

https://doi.org/10.1182/blood.V118.21.145.145

Published: 2011

Journal Articles

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Fabiana Ostronoff, MD, Barry Storer, PhD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J. Martin, MD, Frederick R. Appelbaum, M.D., David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mohamed L. Sorror, MD, MSc

Blood (2011) 118 (21): 665.

https://doi.org/10.1182/blood.V118.21.665.665

Published: 2011

Journal Articles

Transplantation of Peripheral Blood Cells As Compared with Bone Marrow From HLA-Identical Related Donors Is Associated with Superior Long-Term Outcomes

Marco Mielcarek, MD, Barry Storer, PhD, Paul J. Martin, MD, Robert S Negrin, MD, Stephen J. Forman, MD, Mary E.D. Flowers, MD, Yoshihiro Inamoto, MD, Thomas Chauncey, MD, PhD, Rainer Storb, MD, Frederick R. Appelbaum, MD, William I Bensinger, MD

Blood (2011) 118 (21): 319.

https://doi.org/10.1182/blood.V118.21.319.319

Published: 2011

Journal Articles

Umbilical Cord Blood Transplantation in Patients with Hematological Malignancies Using a Non-ATG Containing Reduced Intensity Preparative Regimen

Fabiana Ostronoff, MD, Filippo Milano, MD, PhD, Ted Gooley, Jonathan Gutman, MD, Peter A. McSweeney, MD, Finn Petersen, M.D., Brenda M. Sandmaier, MD, Rainer Storb, MD, Colleen Delaney, MD

Blood (2011) 118 (21): 1943.

https://doi.org/10.1182/blood.V118.21.1943.1943

Published: 2011

NARROW

Clonal Hematopoiesis in Donor-Recipient Pairs after Allogeneic Hematopoietic Cell Transplantation

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Characterization of Clonal Dynamics after Hematopoietic Cell Transplantation Using Ultra-Sensitive Duplex Sequencing

A Prospective Multicenter Study of Nonmyeloablative Conditioning with TBI or Fludarabine/TBI for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and Mycophenolate Mofetil: 10-Year Experience

Anti-CD45 Monoclonal Antibody (MAb) Dose Optimization For Astatine-211 ( 211 At)-Radioimmunotherapy (RIT) Of Relapsed Non-Hodgkin Lymphoma (NHL) In a Canine Model

Modulated Cyclophosphamide-Based In Vivo T-Cell Depletion Promotes Engraftment With Minimal Gvhd and Low Toxicity In Fanconi Anemia Patients

Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

A Phase II Trial Combining Radiolabeled Anti-CD45 Antibody with Fludarabine and Low-Dose Total Body Irradiation (TBI) Followed by Related or Unrelated Hematopoietic Cell Transplantation for Patients Under Age 50 with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Inducible Costimulator (ICOS) Is up-Regulated in Dogs with Graft Versus Host Disease and Graft Rejection Following Non-Identical Hematopoietic Cell Transplantation

Vaccinating Female Donors with Y Chromosome-Encoded Disparities in the Pre-Clinical Canine Model of Allogeneic Hematopoietic Cell Transplantation

Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts

Long-Term Tolerance to Kidney Allografts After Induced Rejection of Donor Hematopoietic Chimerism in a Preclinical Canine Model.

Impact of Pre-Transplant Comorbidities on the Rate of- and Mortality-Following Acute Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Transplantation of Peripheral Blood Cells As Compared with Bone Marrow From HLA-Identical Related Donors Is Associated with Superior Long-Term Outcomes

Umbilical Cord Blood Transplantation in Patients with Hematological Malignancies Using a Non-ATG Containing Reduced Intensity Preparative Regimen

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only